XML 78 R53.htm IDEA: XBRL DOCUMENT v3.23.1
Note 9 - Equity Plans and Related Equity Activities (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Notes Tables    
Share-Based Payment Arrangement, Cost by Plan [Table Text Block]
  

Three Months Ended
March 31,

 
  

2023

  

2022

 

Research and development

 $97  $119 

General and administrative

  390   302 

Total stock-based compensation

 $487  $421 
  

Year Ended
December 31,

 
  

2022

  

2021

 

Research and development

 $583  $292 

General and administrative

  1,300   851 

Total stock-based compensation

 $1,883  $1,143 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]  
  

Year Ended
December 31,

 
  

2022

  

2021

 

Option Grants:

          

Expected term (years)

 5.00-6.06  5.62-10.00 

Expected volatility

 71%-86%   88% 

 

Risk-free interest rate

 0.53%-4.07%  0.60%-1.20% 

Expected dividend

  0% 

 

  0% 

 

ESPP:

          

Expected term (years)

 0.50-2.00      

Expected volatility

 83%-93%      

Risk-free interest rate

 4.37%-4.60%      

Expected dividend

  0% 

 

     
Share-Based Payment Arrangement, Activity [Table Text Block]  
  

Awards Available to Grant

  

Number of Awards Outstanding

  

Weighted Average Exercise Price

  

Weighted Average Remaining Contractual Terms (Years)

  

Aggregate Intrinsic Value

 

Outstanding at December 31, 2021

  888,435   3,536,715  $2.71         

Shares authorized added to 2022 Plan

  2,573,405                 

Shares not returned to plan

  (913,842

)

                

Options Granted

  (2,097,010

)

  2,097,010  $3.18         

Options Exercised

  -   (75,550

)

 $1.45         

Options Cancelled

  839,156   (839,156

)

 $2.43         

Restricted stock awards granted

  (23,518

)

  23,518  $-         

Restricted stock awards vested

  -   (23,518

)

 $-         

Restricted stock units granted

  (243,618

)

  243,618  $-         

Restricted stock units vested

  -   (80,668

)

 $-         

Restricted stock units forfeited

  42,415   (42,415

)

 $-         

Outstanding at December 31, 2022

  1,065,423   4,839,554  $2.91   6.66  $82 

Vested and exercisable at December 31, 2022

      2,685,009  $2.75   4.41  $- 

Vested and expected to vest at December 31, 2022

      4,824,187  $2.91   6.65  $82 
Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]  
    

Awards Outstanding

  

Awards Exercisable

 

Range of Exercise Price

 

Number of Awards

  

Weighted-Average Remaining Contractual Term (Years)

  

Weighted Average Exercise Price per Share

  

Number of Awards

  

Weighted-Average Remaining Contractual Term (Years)

  

Weighted Average Exercise Price per Share

 

$1.27

to$2.65  3,103,997   6.12  $2.08   1,692,935   3.09  $1.68 

$3.03

to$4.79  1,384,481   7.55  $4.38   820,036   6.72  $4.13 

$6.54

to$7.62  230,541   6.83  $6.84   172,038   6.40  $6.69 
     4,719,019   6.58  $2.99   2,685,009   4.41  $2.75